Leadership & Expert Views - Cancer Currents Blog
Commentaries from scientific leaders at NCI and other institutions about cancer research topics, programs, and initiatives.
-
Improving Cancer Control in Rural Communities: An Interview with Dr. Robert CroyleNCI’s Dr. Robert Croyle discusses some of the issues related to cancer control faced by rural communities and how NCI is approaching this important problem.
-
Improving Public Health through Increased Tobacco RegulationNCI’s Dr. Robert Croyle discusses the Food and Drug Administration’s release of a rule that extends its regulatory authority over tobacco products to include cigars, e-cigarettes, hookah (waterpipe) tobacco.
-
Calling on Data Enthusiasts to Help Advance Cancer ResearchHealth data enthusiasts of all stripes were in Washington, D.C., today for Health Datapalooza. NCI's Dr. Warren Kibbe explains that this annual event explores a topic that is central to NCI’s efforts against cancer: creating knowledge from data.
-
The Cancer Community's Next Steps for the Moonshot InitiativeThe National Cancer Moonshot Initiative’s Blue Ribbon Panel is moving quickly to develop recommendations on how to accelerate progress against cancer.
-
A Shared Commitment for Accelerating Progress with the Cancer MoonshotAt the AACR annual meeting, Vice President Biden spoke about the National Cancer Moonshot Initiative and the critical role the entire research community will play in accelerating progress against cancer.
-
Toward Precision Therapy for Children with Cancer: An Interview with Dr. Javed KhanNCI’s Dr. Javed Khan discusses a new NCI clinical program and the promise and challenges of genome-guided therapy for children with cancer.
-
Keeping Pace: How New Data Can Affect Ongoing Clinical TrialsResearch results sometimes outrace the design of an ongoing clinical trial and the trial has to be recalibrated to include newer treatments, according to NCI’s Dr. Jo Anne Zujewski.
-
Fueling Basic Discovery: NCI’s Cooperative Human Tissue NetworkQuality biospecimens are a foundational resource for cancer research. One of NCI’s longest running biospecimen programs is the Cooperative Human Tissue Network, a resource mainly for basic discovery and early translational research.
-
NCI-DOE Collaboration Paving Way for Large-Scale Computational Cancer ScienceNCI and the Department of Energy have entered into a collaboration to develop a plan to use large-scale computing to influence cancer science and, ultimately, clinical treatment.
-
President Obama’s Budget Request Affirms Commitment to Progress against CancerPresident Obama’s FY 2017 Budget Request includes $680 million to support Vice President Biden’s cancer research initiative.
-
Tackling the Global Cancer Burden: A Conversation with NCI’s Dr. Ted TrimbleIn honor of World Cancer Day, the director of NCI’s Center for Global Health discusses key opportunities in global cancer research.
-
The ‘Crisis’ of Low HPV Vaccination Rates: A Conversation with Dr. Noel BrewerFollowing the release of a consensus statement from the NCI-Designated Cancer Centers urging HPV vaccination in the United States, Dr. Noel Brewer discusses the country’s low vaccination rates and how clinicians can help to improve them.
-
NCI-MATCH: A Status Report and Future DirectionsLeaders of the NCI-MATCH trial provide an update to the cancer community on the trial’s status and plans for it moving forward.
-
Opportunities in Cancer Nanotechnology: A Conversation with NCI’s Dr. Piotr GrodzinskiThe director of NCI's Office of Cancer Nanotechnology Research discusses the Cancer Nanotechnology Plan 2015, as well as new developments and clinical opportunities in the field.
-
Supporting Vice President Biden's Cancer InitiativeDuring his 2016 State of the Union address to Congress, President Obama tasked Vice President Biden with leading a new initiative to accelerate cancer research. This message from NCI Acting Director Doug Lowy states that the Institute stands ready to work with partners across the cancer research community on the initiative.
-
Checking In on Cancer Checkpoint InhibitorsNCI’s Dr. James Gulley discusses cancer checkpoint inhibitors, their impact on patient care, and future directions for these therapies.
-
Lung Cancer Precision Medicine Trials: Adapting to ProgressPatients with lung cancer are benefiting from the boom in targeted and immune-based therapies. With a series of precision medicine trials, NCI is keeping pace with the rapidly changing treatment landscape for lung cancer.
-
How Genomics Is Shaping Precision Medicine in OncologyIn laboratories at NCI and around the world, researchers are using advanced genomic technologies to study the differences between cancer cells and normal cells, leading to new and more effective treatments for patients with cancer.
-
A Holistic Approach to Cancer Health DisparitiesRecognizing that complex factors underlie health disparities, NCI is taking a holistic approach in our efforts to address this serious public health issue.
-
Bringing Cancer Research to the Public: NCI’s Networks and ProgramsA number of NCI programs and networks are the foundation of the National Cancer Program and play a critical role in promoting progress.